P03372 (ESR1_HUMAN) Homo sapiens (Human)
Estrogen receptor UniProtKBInterProSTRINGInteractive Modelling
595 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4);
1 identical sequence: Homo sapiens: G4XH65
It is possible new templates exist for this target since these models were created.
Available Structures
438 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Oxabicyclic Heptene… |
Heteromer Q15596; | 2×OBH; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol deriv… |
Heteromer Q15596; | 2×7FR; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Oxabicyclic Heptene… |
Heteromer Q15596; | 2×OBH; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-naphthyl-substituted, m… |
Heteromer Q15596; | 2×5C8; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Methoxy-substit… |
Heteromer Q15596; | 2×4Q7; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compou… |
Heteromer Q15596; | 2×7E1; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a 2-Chloro-substituted Tria… |
Heteromer Q15596; | 2×5G5; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoromethyl-substitut… |
Heteromer Q15596; | 2×5CE; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS derivative… |
Heteromer Q15596; | 2×7FP; | ||||
| Assess | ||||||
| Crystal structure of human Estrogen Receptor Alpha Ligand-Binding Domain in complex with a Glucocor… |
Heteromer Q9WUI9; | 2×J3Z; | ||||
| Assess | ||||||
| HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX… |
Heteromer Q15596; | 2×ZTW; | ||||
| Assess | ||||||
| Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-1M-G and A Glucocorticoid … |
Heteromer Q15596; | 2×T3O; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with estradiol |
Heteromer Q15788; | 2×EST; 3×GOL; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with 4-tert-octylphenol |
Heteromer Q15788; | 2×27L; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-methyl, 2-chlo… |
Heteromer Q15596; | 3×OB3; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalanol |
Heteromer Q15788; | 2×27J; 1×GOL; 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with HPTE |
Heteromer Q15788; | 2×27N; 1×GOL; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with octane-1,8-diyl bis… |
Heteromer Q15596; | 2×7ED; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Fluoro-substitu… |
Heteromer Q15596; | 3×OBC; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, 4-metho… |
Heteromer Q15596; | 1×OB5; 1×OB4; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a phenylamino-substituted, … |
Heteromer Q15596; | 2×5C4; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5KA; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5KG; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with ferutinine |
Heteromer Q15788; | 2×27H; 2×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Cyclofenil-ASC … |
Heteromer Q15596; | 2×7FG; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a triaryl-ethylene compound… |
Heteromer Q15596; | 2×5DJ; | ||||
| Assess | ||||||
| Crystal structure of ERa LBD in complex with RU100132 |
Heteromer P70365; | 2×0L8; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain in complex with 2-(but-1-enyl)-17beta-estradiol… |
Heteromer Q15596; | 2×DRQ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 4-Bromo-substitut… |
Heteromer Q15596; | 2×OBM; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compou… |
Heteromer Q15596; | 2×7JY; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Zearalenone |
Heteromer Q15596; | 2×ZER; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol deriv… |
Heteromer Q15596; | 2×7FS; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, 4-chlor… |
Heteromer Q15596; | 1×OB7; 1×OB6; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain complexed with Burned Meat C… |
Heteromer Q61026; | 2×1HP; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with TCBPA |
Heteromer Q15788; | 2×XDH; 2×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 3-Fluoro-substitu… |
Heteromer Q15596; | 2×OFB; | ||||
| Assess | ||||||
| Crystal Structure of human Estrogen Receptor alpha Ligand-Binding Domain in complex with a Glucocor… |
Heteromer Q9WUI9; | 1×CL; 1×GOL; 2×4OH; | ||||
| Assess | ||||||
| Crystal structure of the ER alpha ligand binding domain with the agonist ortho-trifluoromethylpheny… |
Heteromer Q15596; | 2×EZT; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative d… |
Heteromer Q15596; | 2×5K8; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicycli… |
Heteromer Q61026; | 2×HZ3; | ||||
| Assess | ||||||
| HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOC… |
Heteromer Q15596; | 1×CL; 2×DES; 2×ACY; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5K4; | ||||
| Assess | ||||||
| Crystal structure of human estrogen receptor alpha LBD in complex with GRIP peptide and estriol |
Heteromer Q15596; | 1×ESL; 4×CL; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with chlordecone |
Heteromer Q15788; | 1×EDO; 2×27E; 3×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained … |
Heteromer Q15596; | 1×1GJ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a para-Hydroxyl-substituted… |
Heteromer Q15596; | 2×5FY; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with benzylbutylphtalate |
Heteromer Q15788; | 2×27G; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a t-butyl-substituted, meth… |
Heteromer Q15596; | 2×5C7; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Dynamic WAY der… |
Heteromer Q15596; | 2×6WL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,3-bis(2-chloro-4-… |
Heteromer Q15596; | 2×7EN; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with bisphenol-A |
Heteromer Q15788; | 2×2OH; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5JY; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Arene Core OBHS… |
Heteromer Q15596; | 2×7M7; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a difluoro-substituted A-CD… |
Heteromer Q15596; | 2×5CK; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5K0; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Coumestrol |
Heteromer Q15596; | 2×CUE; | ||||
| Assess | ||||||
| Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-3M and A Glucocorticoid Re… |
Heteromer Q15596; | 2×689; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Burned Meat Com… |
Heteromer Q61026; | 2×PIQ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Oxabicyclic Heptene… |
Heteromer Q15596; | 2×OB1; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Methyl-substitu… |
Heteromer Q15596; | 2×4Q9; | ||||
| Assess | ||||||
| Crystal Structure of Estrogen Receptor Alpha mutant 537S Complexed with 4-(6-hydroxy-1H-indazol-3-y… |
Heteromer Q61026; | 2×KN2; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the imidazopyridine… |
Heteromer Q15596; | 2×5P1; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex the 3,4-diaryl-furan der… |
Heteromer Q15596; | 2×5OS; | ||||
| Assess | ||||||
| ER-PRS*(+) (Y537S) in complex with estradiol and SRC-2 coactivator peptide |
Heteromer Q15596; | 2×EST; 14×EDO; 5×GOL; 1×NA; 1×CL; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with WAY-169916 |
Heteromer Q61026; | 2×KN1; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain in complex with OBCP-1M and a glucocorticoid re… |
Heteromer Q15596; | 2×458; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with G… |
Heteromer Q61026; | 2×GEN; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the ACD-ring estrog… |
Heteromer Q15596; | 2×7FZ; | ||||
| Assess | ||||||
| Crystal Structure of Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with an Et… |
Heteromer Q61026; | 2×EI1; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the AC-ring estroge… |
Heteromer Q15596; | 2×7G0; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalenol |
Heteromer Q15788; | 2×36J; 4×GOL; 2×EDO; | ||||
| Assess | ||||||
| The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with Estradiol and a gluc… |
Heteromer Q15596; | 2×EST; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5KF; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-trifluoroethyl… |
Heteromer Q15596; | 3×OB9; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-… |
Heteromer Q15596; | 2×1GT; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained … |
Heteromer Q15596; | 2×1GU; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compou… |
Heteromer Q15596; | 2×7K6; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with butylparaben |
Heteromer Q15788; | 2×27K; 2×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 4-Fluoro-subst… |
Heteromer Q15596; | 2×5J2; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-… |
Heteromer Q15596; | 2×KN3; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-((1,3-dihydro-… |
Heteromer Q15596; | 2×7FJ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 3-m… |
Heteromer Q15596; | 2×5EU; | ||||
| Assess | ||||||
| Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-2M and A Glucocorticoid Re… |
Heteromer Q15596; | 2×459; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with biochanin A |
Heteromer Q15788; | 2×QSO; 2×GOL; 1×EDO; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Ethoxytriphenylethylene … |
Heteromer Q15596; | 2×Q97; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 3,4-bis(2-fluoro-4-… |
Heteromer Q15596; | 2×7ER; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with benzophenone-2 |
Heteromer Q15788; | 2×27M; 4×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5JX; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Arene Core OBHS… |
Heteromer Q15596; | 2×7M1; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 3,4… |
Heteromer Q15596; | 2×5G2; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Constrained WAY… |
Heteromer Q15596; | 2×7EF; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol deriv… |
Heteromer Q15596; | 2×7FQ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5KB; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the PEG-linked Dime… |
Heteromer Q15596; | 2×7EE; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5J1; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compou… |
Heteromer Q15596; | 2×7EV; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with a Dynamic Th… |
Heteromer Q15596; | 2×1GV; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicy… |
Heteromer Q15596; | 2×5FT; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the A-CD ring estro… |
Heteromer Q15596; | 2×6WU; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with an methyl-substituted A-CD … |
Heteromer Q15596; | 2×5CQ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5HW; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained … |
Heteromer Q15596; | 1×1GM; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Cyclofenil-ASC … |
Heteromer Q15596; | 2×7FD; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY … |
Heteromer Q15596; | 2×1GQ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-(thiophene-2,3… |
Heteromer Q15596; | 2×7ES; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS analog, 4-… |
Heteromer Q15596; | 2×7FO; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with a Chloro-Inda… |
Heteromer Q61026; | 2×EES; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5HZ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE |
Heteromer Q15596; | 1×6WS; 1×6WT; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-(cycloheptylid… |
Heteromer Q15596; | 2×7FL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compou… |
Heteromer Q15596; | 2×7J9; | ||||
| Assess | ||||||
| Crystal Structure of Estrogen Receptor alpha Complexed to a B-N Substituted Ligand |
Heteromer Q61026; | 2×A48; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an a-naphthyl Subst… |
Heteromer Q15596; | 2×6WP; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicycli… |
Heteromer Q61026; | 2×ODE; | ||||
| Assess | ||||||
| Crystal structure of human Estrogen Receptor Alpha Ligand-Binding Domain in complex with a Glucocor… |
Heteromer Q9WUI9; | 2×J2Z; | ||||
| Assess | ||||||
| ER-PRS*(+) (Y537S) in complex with genistein and SRC-2 coactivator peptide |
Heteromer Q15596; | 2×GEN; 3×NA; 16×EDO; 3×CL; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-trifluoroethyl… |
Heteromer Q15596; | 2×OBT; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain in complex with 17methyl-17alpha-dihydroequilen… |
Heteromer Q15596; | 2×17M; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-methyl Substit… |
Heteromer Q15596; | 2×OB2; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with propylparaben |
Heteromer Q15788; | 2×36M; 5×GOL; 2×EDO; 2×PEG; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 3-Bromo-substitut… |
Heteromer Q15596; | 2×OBB; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with an A-CD ring… |
Heteromer Q15596; | 2×ESE; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with a Dynamic Ox… |
Heteromer Q15596; | 2×15Q; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Diethylstilbestrol |
Heteromer Q15596; | 2×DES; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5KE; | ||||
| Assess | ||||||
| Dual Modulators |
Heteromer Q15596; | 2×LYQ; 2×WVE; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5KD; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, alpha-n… |
Heteromer Q15596; | 2×OB8; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (Y537S) in complex with bisphenol-AF |
Heteromer Q15788; | 2×0CZ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-BSC Analog… |
Heteromer Q15596; | 1×7EH; 1×7ET; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Spiro BC-estrad… |
Heteromer Q15596; | 2×7G1; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain and a glucocorticoid receptor-interacting prote… |
Heteromer Q15596; | |||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 3,4-bis(4-hydroxyph… |
Heteromer Q15596; | 2×7EH; 4×7G5; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-… |
Heteromer Q15596; | 2×1GR; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with an Inhibitor 30a and GRI… |
Heteromer Q15788; | 2×IAT; 2×PEG; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to an Ether Estrad… |
Heteromer Q61026; | 2×EED; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC analog… |
Heteromer Q15596; | 2×7M4; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Resveratrol |
Heteromer Q15596; | 2×STL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5HX; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with an Inhibitor 30o and GRI… |
Heteromer Q15788; | 1×PEG; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-4,4''-dihydroxy… |
Heteromer Q15596; | 2×7EG; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-3'-fluoro-4'-hy… |
Heteromer Q15596; | 3×7G2; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative m… |
Heteromer Q15596; | 2×5K7; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoro-substituted A-C… |
Heteromer Q15596; | 2×5CJ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 2,5… |
Heteromer Q15596; | 2×5ET; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 16-benzylidene estr… |
Heteromer Q15596; | 2×6WN; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 16b-benzyl 17b-estr… |
Heteromer Q15596; | 2×6WM; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC Analog… |
Heteromer Q15596; | 4×7E3; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain C381S C417S Y537S Mutant in Complex with an Covalent … |
Heteromer Q15596; | 1×PEG; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicy… |
Heteromer Q15596; | 2×5FV; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5K2; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a phenylamino-substituted e… |
Heteromer Q15596; | 2×5CC; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with a Squaric Acid-link… |
Heteromer Q15596; | 2×7EE; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dimethyl-substituted, 3,4… |
Heteromer Q15596; | 2×5FS; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained … |
Heteromer Q15596; | 2×1GS; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Triaryl-substituted Imi… |
Heteromer Q15596; | 2×5G4; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 3… |
Heteromer Q15596; | 2×5J0; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-sub… |
Heteromer Q15596; | 2×6WV; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 4-fluorophenylamino-subst… |
Heteromer Q15596; | 2×5ES; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-((5-bromo-2,3-… |
Heteromer Q15596; | 2×6WQ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 4-fluorophenylamino-subst… |
Heteromer Q15596; | 2×5DG; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-methylphenylamino-subst… |
Heteromer Q15596; | 3×5C9; | ||||
| Assess | ||||||
| HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRB… |
Heteromer Q15596; | 1×EST; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the A-CD ring estro… |
Heteromer Q15596; | 2×6WR; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the imidazopyridine… |
Heteromer Q15596; | 2×5OR; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-2-chloro-4'-hyd… |
Heteromer Q15596; | 2×7EL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 2-Chloro-subst… |
Heteromer Q15596; | 2×5G3; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5K5; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 2-naphthylamino-substitut… |
Heteromer Q15596; | 2×5C6; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-4'-hydroxy-3-((… |
Heteromer Q15596; | 2×7G3; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Fluoro-Resve… |
Heteromer Q15596; | 2×FSV; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain in complex with estradiol and the E2#23 FN3 mon… |
Heteromer P02751; | 2×EST; | ||||
| Assess | ||||||
| Dual Modulators |
Heteromer Q15596; | 1×WVW; 1×WVR; | ||||
| Assess | ||||||
| Human Estrogen Receptor alpha Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,1… |
Heteromer Q61026; | 1×CL; 2×ETC; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Methyl(phenyl)a… |
Heteromer Q15596; | 2×6WW; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,5-bis(2-fluoro-4-… |
Heteromer Q15596; | 2×7EQ; | ||||
| Assess | ||||||
| Apo Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant with a glucocorticoid receptor-inter… |
Heteromer Q15596; | |||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-SP2… |
Heteromer Q15596; | 2×EST; 2×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a 2-Methyl-substituted Tria… |
Heteromer Q15596; | 2×5G7; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-BCP1 |
Heteromer Q15596; | 2×EST; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a nitrile-substituted triar… |
Heteromer Q15596; | 2×5DH; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer Q15596; | 2×5K1; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4',4''-(thiophene… |
Heteromer Q15596; | 2×7EM; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Z2OHTPE and a glucocorti… |
Heteromer Q15596; | 2×FNJ; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P4 … |
Heteromer Q15596; | 2×EST; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P5 |
Heteromer Q15596; | 2×EST; 2×GOL; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P1 … |
Heteromer Q15596; | 2×EST; 2×GOL; 1×CL; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P3 … |
Heteromer Q15596; | 2×EST; 1×CL; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with TTC-352 and GRIP Peptide |
Heteromer Q15596; | 2×V9J; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 3-(((2-chloro-5-phenylthieno[2,… |
Heteromer Q15596; | 2×98L; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with 2-(2-Chloro-5-phenylthie… |
Heteromer E7EWM1; | 2×61Z; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with 3OHTPE and GRIP Peptide |
Heteromer Q15596; | 2×FYS; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,5-bis(2-chloro-4-… |
Heteromer Q15596; | 2×7EO; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 4-(((2-chloro-5-phenylthieno[2,… |
Heteromer Q15596; | 1×5VP; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Triaryl-imine analog 4,4'… |
Heteromer Q15596; | 2×5G6; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 2-chloro-4-((4-hydroxybenzyl)am… |
Heteromer Q15596; | 1×EMY; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC Analog… |
Heteromer Q15596; | 5×7KL; | ||||
| Assess | ||||||
| Solution nmr-derived structure of calmodulin c-lobe bound with er alpha peptide |
Heteromer P0DP33; | 2×CA; | ||||
| Assess | ||||||
| Solution NMR-derived structure of calmodulin N-lobe bound with ER alpha peptide |
Heteromer P0DP33; | 2×CA; | ||||
| Assess | ||||||
| Solution NMR-derived structure of calmodulin bound with ER alpha peptides |
Heteromer P0DP33; | 4×CA; | ||||
| Assess | ||||||
| Cucurbit[8]uril and 14-3-3 based binary bivalent supramolecular-protein assembly platform |
Heteromer P31946; | 1×GOL; 1×C8L; | ||||
| Assess | ||||||
| Structural Basis of Estrogen Receptor Alpha Methylation Mediated by Histone Methyltransferase SmyD2 |
Heteromer Q9NRG4; | 3×ZN; 1×SAH; 1×PE8; 2×NI; | ||||
| Assess | ||||||
| Co-soaked stabilizers for ERa - 14-3-3 interaction (844_AZ210) |
Heteromer P31947; | 6×MG; 2×SSX; 2×GEH; | ||||
| Assess | ||||||
| Cys-42-tethered stabilizer 8 of 14-3-3(sigma)/ERa PPI |
Heteromer P31947; | 4×MG; 2×T5Q; | ||||
| Assess | ||||||
| Cys-42-tethered stabilizer 6 of 14-3-3(sigma)/ERa PPI |
Heteromer P31947; | 6×MG; 2×T5N; | ||||
| Assess | ||||||
| Cys-42-tethered stabilizer 7 of 14-3-3(sigma)/ERa PPI |
Heteromer P31947; | 6×MG; 2×T5T; | ||||
| Assess | ||||||
| Co-soaked stabilizers for ERa - 14-3-3 interaction (884_AZ354) |
Heteromer P31947; | 6×MG; 2×GEH; 2×LF5; | ||||
| Assess | ||||||
| Cys-42-tethered stabilizer 12 of 14-3-3(sigma)/ERa PPI |
Heteromer P31947; | 6×MG; 2×T5Z; | ||||
| Assess | ||||||
| co-soaked stabilizers for ERa - 14-3-3 interaction (884_AZ244) |
Heteromer P31947; | 6×MG; 2×GEH; 2×SG0; | ||||
| Assess | ||||||
| Cys-45-tethered stabilizer 4 of 14-3-3(sigma)/ERa PPI |
Heteromer P31947; | 2×MG; 2×T4Q; | ||||
| Assess | ||||||
| Cys-45-tethered stabilizer 5 of 14-3-3(sigma)/ERa PPI |
Heteromer P31947; | 6×MG; 2×T4Z; | ||||
| Assess | ||||||
| Human 14-3-3 sigma in complex with human Estrogen Receptor alpha peptide |
Heteromer P31947; | |||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1074372) |
Heteromer P31947; | 6×MG; 2×RZL; | ||||
| Assess | ||||||
| Cys-42-tethered stabilizer 10 of 14-3-3(sigma)/ERa PPI |
Heteromer P31947; | 2×MG; 2×T6H; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1074361) |
Heteromer P31947; | 6×MG; 2×U0L; | ||||
| Assess | ||||||
| Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C45 mutant bound to disulfide f… |
Heteromer P31947; | 4×MG; 2×GE8; | ||||
| Assess | ||||||
| single soak stabilizer for ERa - 14-3-3 interaction (AZ275) |
Heteromer P31947; | 6×MG; 2×SDM; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1074361) |
Heteromer P31947; | 6×MG; 2×S0O; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1083744) |
Heteromer P31947; | 6×MG; 2×NJ3; | ||||
| Assess | ||||||
| single soak stabilizer for ERa - 14-3-3 interaction (AZ555) |
Heteromer P31947; | 6×MG; 2×L1T; | ||||
| Assess | ||||||
| Cys-42-tethered stabilizer 13 of 14-3-3(sigma)/ERa PPI |
Heteromer P31947; | 6×MG; 2×T6W; | ||||
| Assess | ||||||
| single soak stabilizer for ERa - 14-3-3 interaction (AZ354) |
Heteromer P31947; | 4×MG; 4×LF5; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1076394) |
Heteromer P31947; | 4×MG; 2×NK6; | ||||
| Assess | ||||||
| Small molecule stabilizer (compound 1) for ERalpha and 14-3-3 |
Heteromer P31947; | 4×MG; 2×O6C; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3sigma (1074378) |
Heteromer P31947; | 6×MG; 2×NR6; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1080297) |
Heteromer P31947; | 4×MG; 2×O3F; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1080272) |
Heteromer P31947; | 4×MG; 2×MVU; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1075311) |
Heteromer P31947; | 6×MG; 2×MU9; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1080267) |
Heteromer P31947; | 6×MG; 2×NF9; | ||||
| Assess | ||||||
| Small molecule stabilizer for ERalpha and 14-3-3 (1074359) |
Heteromer P31947; | 6×MG; 2×N1R; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1080266) |
Heteromer P31947; | 6×MG; 2×NKL; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1080299) |
Heteromer P31947; | 6×MG; 2×OT0; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1074202 - non covalent) |
Heteromer P31947; | 6×MG; 2×O4I; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (AZ210) |
Heteromer P31947; | 4×MG; 2×SD7; | ||||
| Assess | ||||||
| Small molecule stabilizer (1075481) for ERalpha and 14-3-3 |
Heteromer P31947; | 6×MG; 2×O0O; | ||||
| Assess | ||||||
| Ternary structure of 14-3-3sigma, PKA-responsive ERa phosphopeptide and Fusicoccin-A |
Heteromer P31947; | 6×MG; 2×SIT; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1080265) |
Heteromer P31947; | 6×MG; 2×NJI; | ||||
| Assess | ||||||
| Small molecule stabilizer for ERalpha and 14-3-3 (1080269) |
Heteromer P31947; | 2×MG; 2×NUO; | ||||
| Assess | ||||||
| small molecule stabilizer for ERalpha and 14-3-3 (1083743) |
Heteromer P31947; | 6×MG; 2×NJC; | ||||
| Assess | ||||||
| Small molecule stabilizer for ERalpha and 14-3-3 (1075478) |
Heteromer P31947; | 6×MG; 2×N0L; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1075302) |
Heteromer P31947; | 6×MG; 2×SOI; | ||||
| Assess | ||||||
| Small molecule amidine soak in 14-3-3/ERa (AZ037) |
Heteromer P31947; | 6×MG; 2×TG9; | ||||
| Assess | ||||||
| Ternary complex of 14-3-3 sigma, Estrogen Receptor alfa phosphopeptide, and WQ178 |
Heteromer P31947; | 6×MG; 2×CL; 4×0B7; | ||||
| Assess | ||||||
| Cys-42-tethered stabilizer 9 of 14-3-3(sigma)/ERa PPI |
Heteromer P31947; | 6×MG; 2×T5W; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1080273) |
Heteromer P31947; | 6×MG; 2×NQU; | ||||
| Assess | ||||||
| Small molecule amidine soak in 14-3-3/ERa (AZ132) |
Heteromer P31947; | 6×MG; 2×KM8; | ||||
| Assess | ||||||
| Cys-42-tethered stabilizer 11 of 14-3-3(sigma)/ERa PPI |
Heteromer P31947; | 6×MG; 2×T6N; | ||||
| Assess | ||||||
| Human 14-3-3 sigma in complex with human Estrogen Receptor alpha peptide and ligands Fusicoccin-A a… |
Heteromer P31947; | 2×FSC; 2×UGH; | ||||
| Assess | ||||||
| Small molecule stabilizer for ERalpha and 14-3-3 (1076406) |
Heteromer P31947; | 6×MG; 2×NQ0; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1076397) |
Heteromer P31947; | 6×MG; 2×MRF; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1080294) |
Heteromer P31947; | 2×MG; 2×NIB; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1076405) |
Heteromer P31947; | 6×MG; 2×ND9; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1076398) |
Heteromer P31947; | 4×MG; 2×NQL; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1075310) |
Heteromer P31947; | 4×MG; 2×MVO; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1080300) |
Heteromer P31947; | 6×MG; 2×NG9; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1076402) |
Heteromer P31947; | 6×MG; 2×NQ9; | ||||
| Assess | ||||||
| Small molecule stabilizer for ERalpha and 14-3-3 (1080298) |
Heteromer P31947; | 6×MG; 2×O2X; | ||||
| Assess | ||||||
| FC-J acetonide stabilizer of 14-3-3 and ERalpha |
Heteromer P31947; | 6×MG; 2×SJ4; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1076403) |
Heteromer P31947; | 6×MG; 2×MV3; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1080295) |
Heteromer P31947; | 4×MG; 2×NE9; | ||||
| Assess | ||||||
| Small molecule stabilizer for ERalpha and 14-3-3 (1075297) |
Heteromer P31947; | 6×MG; 2×O6L; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1074398) |
Heteromer P31947; | 2×S8O; | ||||
| Assess | ||||||
| Fragment-linked stabilizer for ERa - 14-3-3 interaction (1075293) |
Heteromer P31947; | 2×S2E; | ||||
| Assess | ||||||
| Fragment-linked stabilizer for 14-3-3 and ERa (1075298) |
Heteromer P31947; | 2×RZT; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3sigma (1080268) |
Heteromer P31947; | 6×MG; 2×M79; | ||||
| Assess | ||||||
| Ternary complex of 14-3-3 sigma, Estrogen Receptor alfa phosphopeptide, and WQ162 |
Heteromer P31947; | 4×09W; 2×BME; 2×CL; 4×MG; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1074393) |
Heteromer P31947; | 2×S3I; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1074392) |
Heteromer P31947; | 2×RZC; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1075305) |
Heteromer P31947; | 6×MG; 2×O49; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1075316) |
Heteromer P31947; | 6×MG; 2×S7R; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1075296) |
Heteromer P31947; | 2×S3U; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1074395) |
Heteromer P31947; | 2×SE3; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1080291) |
Heteromer P31947; | 6×MG; 2×NJR; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1075313) |
Heteromer P31947; | 2×RY0; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1074399) |
Heteromer P31947; | 2×S1R; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1075287) |
Heteromer P31947; | 2×S1I; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1080293) |
Heteromer P31947; | 6×MG; 2×O3O; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1074386) |
Heteromer P31947; | 2×RYR; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1074397) |
Heteromer P31947; | 6×MG; 2×S0U; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interactions (1075288) |
Heteromer P31947; | 2×S7I; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1074388) |
Heteromer P31947; | 2×S2U; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1075292) |
Heteromer P31947; | 2×S86; | ||||
| Assess | ||||||
| Small molecule stabilizer for ERalpha and 14-3-3 (1075306) |
Heteromer P31947; | 6×MG; 2×O5I; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1047455) |
Heteromer P31947; | 2×S6X; | ||||
| Assess | ||||||
| SET7/9-ER-AdoHcy complex |
Heteromer Q8WTS6; | 1×SAH; 3×BME; 1×GOL; | ||||
| Assess | ||||||
| Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f… |
Heteromer P31947; | 6×MG; 2×G8Q; | ||||
| Assess | ||||||
| co-soak stabilizers for ERa - 14-3-3 interaction (884_AZ275) |
Heteromer P31947; | 6×MG; 2×GEH; 2×SH9; | ||||
| Assess | ||||||
| Cys-45-tethered stabilizer 3 of 14-3-3(sigma)/ERa PPI |
Heteromer P31947; | 4×MG; 2×T4W; | ||||
| Assess | ||||||
| fragment-linked stabilizer for ERa - 14-3-3 interaction (1047648) |
Heteromer P31947; | 2×S6O; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1075299) |
Heteromer P31947; | 6×MG; 2×O3T; | ||||
| Assess | ||||||
| Small molecule stabilizer for ERalpha and 14-3-3 (1074210) |
Heteromer P31947; | 4×MG; 2×ODC; | ||||
| Assess | ||||||
| Small molecular stabilizer for ERalpha and 14-3-3 (1075300) |
Heteromer P31947; | 4×MG; 2×O4R; | ||||
| Assess | ||||||
| small molecule stabilizer for ERalpha and 14-3-3 (1074202) |
Heteromer P31947; | 6×MG; 2×O4I; | ||||
| Assess | ||||||
| Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f… |
Heteromer P31947; | 6×MG; 2×G8T; | ||||
| Assess | ||||||
| Ternary complex of Estrogen Receptor alpha peptide and 14-3-3 sigma C42 mutant bound to disulfide f… |
Heteromer P31947; | 6×MG; 2×G4Z; | ||||
| Assess | ||||||
| Ternary complex of 14-3-3 sigma, Estrogen Receptor alfa phosphopeptide, and WQ136 |
Heteromer P31947; | 6×0AW; 4×MG; 2×CL; 2×BME; | ||||
| Assess | ||||||
| Crystal structure of an Estrogen Receptor alpha 8-mer phosphopeptide in complex with 14-3-3sigma st… |
Heteromer P31947; | 4×MG; 4×NE5; | ||||
| Assess | ||||||
| 14-3-3 protein interaction with Estrogen Receptor Alpha provides a novel drug target interface |
Heteromer P31947; | 6×MG; | ||||
| Assess | ||||||
| 14-3-3 protein interaction with Estrogen Receptor Alpha provides a novel drug target interface |
Heteromer P31947; | 2×FSC; | ||||
| Assess | ||||||
| Crystal structure of 14-3-3 sigma in complex with a C-terminal Estrogen Receptor alpha phosphopepti… |
Heteromer P31947; | 2×MG; 2×PJN; | ||||
| Assess | ||||||
| Crystal structure of an Estrogen Receptor alpha 8-mer phosphopeptide in complex with 14-3-3sigma st… |
Heteromer P31947; | 2×NJW; | ||||
| Assess | ||||||
| Crystal structure of 14-3-3 sigma in complex with a C-terminal Estrogen Receptoralpha phosphopeptid… |
Heteromer P31947; | 2×MG; 2×8CQ; | ||||
| Assess | ||||||
| Set7/9-ER-Sinefungin complex |
Heteromer Q8WTS6; | 1×SFG; 3×BME; 1×GOL; | ||||
| Assess | ||||||
| ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST | homo-6-mer | 6×OHT; 2×BCT; 12×EDO; 4×CA; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-sub… | homo-2-mer | 2×6WV; | ||||
| Assess | ||||||
| WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL | homo-2-mer | 2×EST; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30 | homo-2-mer | 2×73I; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-23 | homo-2-mer | 2×7I5; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-8 | homo-2-mer | 2×7I0; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of hERa-LBD (wt) in complex with bisphenol-C | homo-2-mer | 2×0D1; | ||||
| Assess | ||||||
| MUTANT ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL | homo-2-mer | 2×EST; | ||||
| Assess | ||||||
| Crystal structure of estradiol derived metal chelate and estrogen receptor-ligand binding domain co… | homo-2-mer | 2×EU; 2×EEU; 4×FMT; | ||||
| Assess | ||||||
| Mutant estrogen receptor alpha (ERa) Y537S covalently bound to H3B-6545. | homo-2-mer | 2×ND1; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20 | homo-2-mer | 2×L84; 1×CL; | ||||
| Assess | ||||||
| HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 4-HYDROXYTAMOXIFEN | homo-2-mer | 2×OHT; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9 ANGSTROM RESOLUTION | homo-2-mer | 2×EST; | ||||
| Assess | ||||||
| ERa_L536S (L536S/C381S/C471S,C530S) in complex with a tricyclic indole (compound 6) | homo-2-mer | 2×LVH; | ||||
| Assess | ||||||
| ERa_L536S (L536S/C381S/C471S,C530S) in complex with a bridged tetracyclic indole (compound 8) | homo-2-mer | 2×LRQ; | ||||
| Assess | ||||||
| Oestrogen receptor ligand binding domain in complex with compound 16 | homo-2-mer | 2×QNE; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Y537S covalently bound to antagonist H3B-5942. | homo-2-mer | 2×F3D; 6×EDO; 2×DMS; | ||||
| Assess | ||||||
| A SERM Designed for the Treatment of Uterine Leiomyoma with Unique Tissue Specificity for Uterus an… | homo-2-mer | 2×L4G; | ||||
| Assess | ||||||
| Optimization of a novel binding motif to to (E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylprop… | homo-2-mer | 2×XBR; | ||||
| Assess | ||||||
| Optimization of a novel binding motif to to (E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylprop… | homo-2-mer | 2×GW5; | ||||
| Assess | ||||||
| Oestrogen receptor ligand binding domain in complex with compound 28 | homo-2-mer | 2×QNH; | ||||
| Assess | ||||||
| Crystal Structure of Estrogen Receptor alpha-lasofoxifene complex | homo-2-mer | 2×C3D; | ||||
| Assess | ||||||
| Oestrogen receptor ligand binding domain in complex with compound 18 | homo-2-mer | 2×QNK; | ||||
| Assess | ||||||
| Oxyphenylpropenoic acids as Oral Selective Estrogen Receptor Down- Regulators. | homo-2-mer | 2×85Z; | ||||
| Assess | ||||||
| Human Estrogen receptor alpha LBD with GW368 | homo-2-mer | 2×369; | ||||
| Assess | ||||||
| HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE | homo-2-mer | 2×RAL; | ||||
| Assess | ||||||
| Estrogen receptor mutant L536S | homo-2-mer | 2×L5B; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(1-propylpyrroli… | homo-2-mer | 2×TXK; | ||||
| Assess | ||||||
| HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 19 | homo-2-mer | 2×AIT; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Y537S bound to antagonist H3B-9224. | homo-2-mer | 2×F3D; 2×EDO; | ||||
| Assess | ||||||
| HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 16 | homo-2-mer | 2×AIU; | ||||
| Assess | ||||||
| Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifen… | homo-2-mer | 2×RL4; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(methylamino)eth… | homo-2-mer | 2×TW6; | ||||
| Assess | ||||||
| HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 18 | homo-2-mer | 2×AIJ; | ||||
| Assess | ||||||
| HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 15 | homo-2-mer | 2×AIH; | ||||
| Assess | ||||||
| Stapled Peptides binding to Estrogen Receptor alpha. | homo-2-mer | 2×EST; | ||||
| Assess | ||||||
| Benzopyrans as Selective Estrogen Receptor b Agonists (SERBAs). Part 2: Structure Activity Relation… | homo-2-mer | 2×WST; | ||||
| Assess | ||||||
| Human Estrogen Receptor Alpha Ligand-binding Domain in Complex with the Antagonist Ligand 4-D | homo-2-mer | 2×E4D; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain in complex with compound 4 | homo-2-mer | 2×CM4; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with Aliphatic SERD S-C10(15) | homo-2-mer | 2×5YR; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain in complex with compound 3F | homo-2-mer | 2×CM3; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH WAY-244 | homo-2-mer | 2×244; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-21 | homo-2-mer | 2×7Q5; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modul… | homo-2-mer | 2×53Q; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S Mutant in Complex with Endoxifen | homo-2-mer | 2×9XY; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative … | homo-2-mer | 2×R3V; | ||||
| Assess | ||||||
| Raloxifene in Complex with Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutation | homo-2-mer | 2×RAL; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative … | homo-2-mer | 2×RL4; | ||||
| Assess | ||||||
| Bazedoxifene in Complex with Y537S Estrogen Receptor Alpha Ligand Binding Domain | homo-2-mer | 2×29S; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with Raloxifene | homo-2-mer | 2×RAL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-29 | homo-2-mer | 2×7OR; 1×TYR; 1×SER; 1×CYS; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(ethylamino)ethoxy)phenyl)-… | homo-2-mer | 2×TWF; | ||||
| Assess | ||||||
| Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand | homo-2-mer | 2×DC8; | ||||
| Assess | ||||||
| Estrogen receptor alpha ligand-binding domain in complex with a SERM | homo-2-mer | 2×LLC; | ||||
| Assess | ||||||
| Estrogen receptor alpha ligand-binding domain complexed to a SERM | homo-2-mer | 2×LLB; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant In Complex with Lasofoxifene | homo-2-mer | 2×C3D; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-((1-butylpyrrolidin-3-yl)metho… | homo-2-mer | 2×TZI; | ||||
| Assess | ||||||
| Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactio… | homo-2-mer | 2×EST; | ||||
| Assess | ||||||
| HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL | homo-2-mer | 2×EST; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1154 | homo-2-mer | 2×86V; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain in complex with compound 11F | homo-2-mer | 2×IOG; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Estradiol and GRIP Pepti… | homo-2-mer | 2×EST; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of Antagonizing Mutant 536S of the Estrogen Receptor Alpha Ligand Binding Domain … | homo-2-mer | 2×RAL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-25 | homo-2-mer | 2×7OI; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1156 | homo-2-mer | 2×85M; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-((1-propylazetidin-3-… | homo-2-mer | 2×TS7; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1074 | homo-2-mer | 2×86Y; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-16 | homo-2-mer | 2×7EI; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-18 | homo-2-mer | 2×7I9; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with RU39411 | homo-2-mer | 2×NYU; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-19 | homo-2-mer | 2×7AI; 1×CL; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-LP1 | homo-2-mer | 2×EST; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene | homo-2-mer | 2×C3D; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30 | homo-2-mer | 2×77I; | ||||
| Assess | ||||||
| Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 1. | homo-2-mer | 2×GQD; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN | homo-2-mer | 2×GEN; | ||||
| Assess | ||||||
| Estrogen Receptor | homo-2-mer | 2×KN0; | ||||
| Assess | ||||||
| X-ray structure of ERalpha LBD bound to a tetrahydroisoquinoline SERM ligand at 2.05A resolution | homo-2-mer | 2×AEJ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC,… | homo-2-mer | 2×7EB; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC,… | homo-2-mer | 2×7EC; | ||||
| Assess | ||||||
| Estrogen Receptor | homo-2-mer | 2×KN3; | ||||
| Assess | ||||||
| Crystal structure of mutant estrogen receptor alpha Y537S in complex with CO9 | homo-2-mer | 2×2I9; | ||||
| Assess | ||||||
| Estrogen Receptor | homo-2-mer | 4×KN1; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-(2-(piperidin-1-yl)et… | homo-2-mer | 2×TT5; | ||||
| Assess | ||||||
| Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of… | homo-2-mer | 2×I0G; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-((2-(1-propylpyrrol… | homo-2-mer | 2×TZ3; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S in Complex with 4-hydroxytamoxifen | homo-2-mer | 2×OHT; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with ((1'-(4-((1-ethylpyrrolidin-3-yl)meth… | homo-2-mer | 2×TTU; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with RAD1901 | homo-2-mer | 2×I0V; | ||||
| Assess | ||||||
| Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa | homo-2-mer | 2×G9J; 1×NI; 1×G91; 2×GOL; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-((1-ethylazetidin-3-yl)oxy)phe… | homo-2-mer | 2×TQF; | ||||
| Assess | ||||||
| Crystal structure of 8-hydroxychromene compound 30 bound to estrogen receptor alpha | homo-2-mer | 1×G9J; 1×ODY; 1×CL; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with SRC2 Stapled Peptide 41A… | homo-2-mer | 2×EST; | ||||
| Assess | ||||||
| The Structure of Estrogen Receptor in Complex with a Selective and Potent Tetrahydroisochiolin Liga… | homo-2-mer | 2×PTI; | ||||
| Assess | ||||||
| Crystal structure of estrogen receptor alpha in complex with receptor degrader 16ab | homo-2-mer | 2×G8Y; 1×GOL; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-((<i>R</i>)-2-me… | homo-2-mer | 2×TVL; | ||||
| Assess | ||||||
| GDC-9545 in complex with estrogen receptor alpha | homo-2-mer | 1×G9J; 1×ZNM; | ||||
| Assess | ||||||
| Crystal structure of estrogen receptor alpha in complex with receptor degrader 6 | homo-2-mer | 2×G9J; 1×U6D; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 4-Hydroxytamoxifen | homo-2-mer | 2×OHT; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 4-Hydroxytamoxifen | homo-2-mer | 2×OHT; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with Bazedoxifene | homo-2-mer | 2×29S; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifen… | homo-2-mer | 2×R3V; | ||||
| Assess | ||||||
| Human Estrogen Receptor alpha Ligand-Binding Domain In Complex With GW5638 | homo-2-mer | 2×GW5; | ||||
| Assess | ||||||
| ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL | homo-2-mer | 2×EST; 6×AU; | ||||
| Assess | ||||||
| ER-PRS*(-) (L536S, L372R) in complex with raloxifene | homo-2-mer | 2×RAL; 8×EDO; 3×CL; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(1-ethylpyrrolidin-3-yl)eth… | homo-2-mer | 2×TU9; | ||||
| Assess | ||||||
| Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 5. | homo-2-mer | 2×VQI; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(1-propylpyrroli… | homo-2-mer | 2×TV3; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-((1-pentylpyrrolidi… | homo-2-mer | 2×TX9; | ||||
| Assess | ||||||
| Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 2. | homo-2-mer | 2×QHG; | ||||
| Assess | ||||||
| A Novel Oral Selective Estrogen Receptor Down-regulator, AZD9496, drives Tumour Growth Inhibition i… | homo-2-mer | 2×KE9; | ||||
| Assess | ||||||
| Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 3. | homo-2-mer | 2×J0W; | ||||
| Assess | ||||||
| Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 4. | homo-2-mer | 2×7QN; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with LSZ102 | homo-2-mer | 2×C6V; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain in complex with compound 1D | homo-2-mer | 2×IOK; | ||||
| Assess | ||||||
| Crystal structure of GDC-0927 bound to estrogen receptor alpha | homo-2-mer | 2×OGJ; | ||||
| Assess | ||||||
| The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with 4-hydroxytamoxifen | homo-2-mer | 2×OHT; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411 | homo-2-mer | 2×QYM; 1×MG; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Desmethyl ICI164,384 Derivative | homo-2-mer | 2×3YJ; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(dimethylamino)ethoxy)pheny… | homo-2-mer | 2×TVX; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-((<i>S</i>)-3-me… | homo-2-mer | 2×TVF; | ||||
| Assess | ||||||
| ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH LSZ102 | homo-2-mer | 2×C6V; 3×GOL; | ||||
| Assess | ||||||
| ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST | homo-2-mer | 2×OHT; | ||||
| Assess | ||||||
| ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH AN AFFINITY-SELECTED COREPRESSOR PEPTIDE | homo-2-mer | 2×RAL; 4×SO4; | ||||
| Assess | ||||||
| Estrogen receptor alpha ligand-binding domain in complex with a benzopyran agonist | homo-2-mer | 2×JJ3; | ||||
| Assess | ||||||
| ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-{4-[(1R)-2-(4-fluorophenyl)-6-… | homo-2-mer | 2×77W; | ||||
| Assess | ||||||
| ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-(4-{(1R)-6-hydroxy-1-methyl-2-… | homo-2-mer | 2×782; | ||||
| Assess | ||||||
| THE CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR DNA-BINDING DOMAIN BOUND TO DNA: HOW RECEPTORS DISCR… | homo-2-mer | 4×ZN; | ||||
| Assess | ||||||
| The oestrogen receptor recognizes an imperfectly palindromic response element through an alternativ… | homo-2-mer | 4×ZN; | ||||
| Assess | ||||||
| ESTROGEN RECEPTOR ALPHA IN COMPLEX WITH COMPOUND 29 | monomer | 1×H09; | ||||
| Assess | ||||||
| OESTROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH COMPOUND 38 | monomer | 1×GZI; | ||||
| Assess | ||||||
| Crystal structure of estrogen receptor alpha in complex with a stabilized peptide antagonist | monomer | 2×PO4; 1×EST; | ||||
| Assess | ||||||
| estrogen receptor alpha in complex with a stabilized peptide antagonist 6 | monomer | 1×EST; | ||||
| Assess | ||||||
| Tricyclic indazoles a novel class of selective estrogen receptor degrader antagonists | monomer | 1×H8W; | ||||
| Assess | ||||||
| DNA RECOGNITION BY THE OESTROGEN RECEPTOR: FROM SOLUTION TO THE CRYSTAL | monomer | 2×ZN; | ||||
| Assess | ||||||
17 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7prw.1.A | monomer | 0.62 | 2×ZN; | 29.28 | ||
| Assess | ||||||
| 7prw.1.B | monomer | 0.61 | 2×ZN; | 29.28 | ||
| Assess | ||||||
| 7wnh.4.A | monomer | 0.59 | 1×ZN; | 28.87 | ||
| Assess | ||||||
| 4nqa.1.A | monomer | 0.59 | 2×ZN; | 33.13 | ||
| Assess | ||||||
| 5uan.1.A | monomer | 0.58 | 1×ZN; | 33.13 | ||
| Assess | ||||||
| 7wnh.2.A | monomer | 0.58 | 2×ZN; | 28.87 | ||
| Assess | ||||||
| 5uan.1.B | monomer | 0.57 | 1×ZN; | 29.62 | ||
| Assess | ||||||
| 7kw7.1.F | monomer | 0.57 | 29.15 | |||
| Assess | ||||||
| 4nqa.1.B | monomer | 0.56 | 1×ZN; | 25.07 | ||
| Assess | ||||||
| 4iqr.1.A | monomer | 0.56 | 2×ZN; | 26.79 | ||
| Assess | ||||||
| 4iqr.1.B | monomer | 0.56 | 2×ZN; | 26.79 | ||
| Assess | ||||||
| 4nqa.2.B | monomer | 0.56 | 2×ZN; | 25.07 | ||
| Assess | ||||||
| 3dzu.1.A | monomer | 0.55 | 2×ZN; | 35.71 | ||
| Assess | ||||||
| 3dzu.1.B | monomer | 0.54 | 24.65 | |||
| Assess | ||||||
| 5uan.1.A | monomer | 0.53 | 1×ZN; | 35.71 | ||
| Assess | ||||||
| 4nqa.1.A | monomer | 0.52 | 2×ZN; | 35.71 | ||
| Assess | ||||||
| 4nqa.2.A | monomer | 0.52 | 1×ZN; | 35.71 | ||
| Assess | ||||||
36 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 7prw.1.B | monomer | 0.65 | 30.71 | ||
| Assess | ||||||
| Isoform 2 | 4nqa.1.A | monomer | 0.64 | 36.29 | ||
| Assess | ||||||
| Isoform 2 | 5uan.1.A | monomer | 0.64 | 36.29 | ||
| Assess | ||||||
| Isoform 2 | 7prw.1.A | monomer | 0.63 | 2×ZN; | 30.71 | |
| Assess | ||||||
| Isoform 2 | 3dzy.1.A | monomer | 0.62 | 2×ZN; | 36.59 | |
| Assess | ||||||
| Isoform 3 | 7ndo.1.A | homo-2-mer | 0.80 | 2×RAL; | 88.16 | |
| Assess | ||||||
| Isoform 3 | 7prw.1.A | monomer | 0.62 | 2×ZN; | 28.70 | |
| Assess | ||||||
| Isoform 3 | 7prw.1.B | monomer | 0.61 | 2×ZN; | 28.70 | |
| Assess | ||||||
| Isoform 3 | 7wnh.4.A | monomer | 0.59 | 1×ZN; | 28.78 | |
| Assess | ||||||
| Isoform 3 | 4nqa.1.A | monomer | 0.58 | 2×ZN; | 32.83 | |
| Assess | ||||||
| Isoform 3 | 5uan.1.A | monomer | 0.58 | 1×ZN; | 32.83 | |
| Assess | ||||||
| Isoform 3 | 5uan.1.B | monomer | 0.57 | 1×ZN; | 29.15 | |
| Assess | ||||||
| Isoform 3 | 7wnh.2.A | monomer | 0.57 | 2×ZN; | 28.78 | |
| Assess | ||||||
| Isoform 3 | 4nqa.1.B | monomer | 0.56 | 1×ZN; | 24.93 | |
| Assess | ||||||
| Isoform 3 | 4nqa.2.B | monomer | 0.56 | 2×ZN; | 24.93 | |
| Assess | ||||||
| Isoform 3 | 7kw7.1.F | monomer | 0.55 | 28.86 | ||
| Assess | ||||||
| Isoform 3 | 4iqr.2.A | monomer | 0.54 | 2×ZN; | 26.71 | |
| Assess | ||||||
| Isoform 3 | 4iqr.2.B | monomer | 0.54 | 2×ZN; | 26.71 | |
| Assess | ||||||
| Isoform 3 | 3dzy.1.B | monomer | 0.54 | 1×ZN; | 24.36 | |
| Assess | ||||||
| Isoform 3 | 3e00.1.A | monomer | 0.53 | 2×ZN; | 35.71 | |
| Assess | ||||||
| Isoform 3 | 5uan.1.A | monomer | 0.52 | 1×ZN; | 35.71 | |
| Assess | ||||||
| Isoform 3 | 4nqa.2.A | monomer | 0.51 | 1×ZN; | 35.71 | |
| Assess | ||||||
| Isoform 4 | 7prw.1.A | monomer | 0.63 | 2×ZN; | 32.13 | |
| Assess | ||||||
| Isoform 4 | 7prw.1.B | monomer | 0.59 | 2×ZN; | 32.13 | |
| Assess | ||||||
| Isoform 4 | 5uan.1.B | monomer | 0.57 | 1×ZN; | 30.32 | |
| Assess | ||||||
| Isoform 4 | 7wnh.4.A | monomer | 0.56 | 1×ZN; | 32.00 | |
| Assess | ||||||
| Isoform 4 | 7wnh.2.A | monomer | 0.55 | 2×ZN; | 32.00 | |
| Assess | ||||||
| Isoform 4 | 7kw7.1.F | monomer | 0.55 | 32.25 | ||
| Assess | ||||||
| Isoform 4 | 4nqa.2.B | monomer | 0.55 | 2×ZN; | 25.93 | |
| Assess | ||||||
| Isoform 4 | 4nqa.1.B | monomer | 0.54 | 1×ZN; | 25.93 | |
| Assess | ||||||
| Isoform 4 | 4iqr.2.A | monomer | 0.54 | 2×ZN; | 27.00 | |
| Assess | ||||||
| Isoform 4 | 3dzu.1.B | monomer | 0.53 | 24.07 | ||
| Assess | ||||||
| Isoform 4 | 4iqr.2.B | monomer | 0.53 | 2×ZN; | 27.00 | |
| Assess | ||||||
| Isoform 4 | 3e00.1.A | monomer | 0.53 | 2×ZN; | 35.23 | |
| Assess | ||||||
| Isoform 4 | 5uan.1.A | monomer | 0.52 | 1×ZN; | 35.23 | |
| Assess | ||||||
| Isoform 4 | 4nqa.2.A | monomer | 0.51 | 1×ZN; | 35.23 | |
| Assess | ||||||